In contrast to our study, several previous studies reported that PD-L1 expression was associated with better prognosis in patients with NSCLC, [16, 28] SCLC, [20] breast cancer, [36] and malignant melanoma [37]. The gene discussed is CD274; the disease is small cell lung carcinoma.